New treatment Xadago to help 100,000 Canadians living with Parkinson’s

News

Author: Parkinson's Life editorsPublished: 5 May 2017

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

News image

More than 100,000 Canadians living with Parkinson’s will benefit from a new product to be launched in the country.

The drug known as ‘Xadago’, currently readily available in several countries across Europe, helps control motor symptoms and complications over a 24-month period.

Xadago will be the first new oral treatment for Parkinson’s in almost 15 years in Canada. On 21 March 2017 the Food and Drug Administration in the US approved the use of Xadago for the treatment of Parkinson’s as an add-on therapy to levodopa/carbidopa.

Go Back

Share this story

Comments


Related articles


Kimchi Korean food

Recipes & Nutrition

Parkinson’s power foods: one-day menus to nourish your brain and body

One-day menu ideas to enrich the microbiome to reduce symptoms

READ MORE

Global update

Dr Parkinson’s birthday – a date to remember

A look back at World Parkinson’s Disease Day through the years

READ MORE

Interviews

Charity Miles: the app “changing the way you see the world”

We talk to the founder of the Charity Miles app

READ MORE